DYNE THERAPEUTICS
Live / Applied — Third extension granted (statement of use) (as of 09 Jan 2026)
What this means for you
Not registered yet, but its 08 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98121697
- Mark type
- Design + words
- Filed
- 08 Aug 2023
- Published for opposition
- 28 May 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for treating muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders; research and development services relating to the treatment of muscle diseases or disorders, cardiac diseases or disorders, metabolic diseases or disorders and central nervous system diseases or disorders
Owner
- Dyne Therapeutics, Inc., Waltham, MA, US
- Dyne Therapeutics, Inc., Waltham, MA, US
Prior registrations
Prosecution history
- 09 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2026 — SOU EXTENSION 3 GRANTED
- 09 Jan 2026 — SOU EXTENSION 3 FILED
- 09 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Jul 2025 — SOU EXTENSION 2 GRANTED
- 08 Jul 2025 — SOU EXTENSION 2 FILED
- 08 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 23 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 May 2024 — PUBLISHED FOR OPPOSITION
- 08 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER